Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy

Ben G. L. Vanneste*, Florian Buettner, Michael Pinkawa, Philippe Lambin, Aswin L. Hoffmann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Web of Science)

Abstract

Background and purpose: To evaluate spatial differences in dose distributions of the ano-rectal wall (ARW) using dose-surface maps (DSMs) between prostate cancer patients receiving intensity-modulated radiation therapy with and without implantable rectum spacer (IMRT+IRS; IMRT-IRS, respectively), and to correlate this with late gastro-intestinal (GI) toxicities using validated spatial and non-spatial normal-tissue complication probability (NTCP) models.

Materials and methods: For 26 patients DSMs of the ARW were generated. From the DSMs various shape-based dose measures were calculated at different dose levels: lateral extent, longitudinal extent, and eccentricity. The contiguity of the ARW dose distribution was assessed by the contiguous-DSH (cDSH). Predicted complication rates between IMRT+IRS and IMRT-IRS plans were assessed using a spatial NTCP model and compared against a non-spatial NTCP model.

Results: Dose surface maps are generated for prostate radiotherapy using an IRS. Lateral extent, longitudinal extent and cDSH were significantly lower in IMRT+IRS than for IMRT-IRS at high-dose levels. Largest significant differences were observed for cDSH at dose levels >50 Gy, followed by lateral extent at doses >57 Gy, and longitudinal extent in anterior and superior-inferior directions. Significant decreases (p = 0.01) in median rectal and anal NTCPs (respectively, Gr 2 late rectal bleeding and subjective sphincter control) were predicted when using an IRS.

Conclusions: Local-dose effects are predicted to be significantly reduced by an IRS. The spatial NTCP model predicts a significant decrease in Gr 2 late rectal bleeding and subjective sphincter control. Dose constraints can be improved for current clinical treatment planning. (C) 2018 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.

Original languageEnglish
Pages (from-to)17-24
Number of pages8
JournalClinical and Translational Radiation Oncology
Volume14
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Prostate cancer
  • Radiotherapy
  • Rectum spacer
  • Dose-surface maps
  • Toxicity reduction
  • QUALITY-OF-LIFE
  • POLYETHYLENE-GLYCOL HYDROGEL
  • MODULATED RADIATION-THERAPY
  • GASTROINTESTINAL TOXICITY
  • CONFORMAL RADIOTHERAPY
  • BALLOON
  • TRIAL
  • BRACHYTHERAPY
  • HISTOGRAMS
  • REDUCTION

Cite this